https://clinicaltrials.gov/ct2/show/NCT05861102?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=05%2F02%2F2023&lupd_d=14&sort=nwst
STUDY TITLE:
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
DESCRIPTION:
Condition: Ankylosing Spondylitis
Interventions: Drug: Jaktinib; Drug: Placebo
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Not yet recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT05861102
FIRST POSTED:
Tue, 16 May 2023 12:00:00 EDT
LAST UPDATE POSTED:
05/16/23 09:00AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT05861102?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=05%2F02%2F2023&lupd_d=14&sort=nwst